Lycia Therapeutics

View the org chart displaying its 14 main executives

Most searched biographies at Lycia Therapeutics

• Aetna Wun Trombley, Chief Executive Officer
• Clare Ozawa, Director
• Laurent Fischer, Director

Popular executive movements at Lycia Therapeutics

• Jason Lewis, Vice President and Head of Chemistry, has left the company  (posted on March 11 2024).

Create your alert
to follow the executive moves at Lycia Therapeutics.

Lycia Therapeutics has 2,275 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on April 18 2024).
• Vertex Pharmaceuticals has announced the acquisition of Alpine Immune Sciences  (posted on April 16 2024).
• Nurix Therapeutics has just announced a $175 Million fundraising (posted on April 13 2024).

Popular contacts in Biotechnology

• Vik Bajaj - Director at Interline Therapeutics
• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Lycia Therapeutics

• Lycia Therapeutics Announces $70 Million Series B Financing Led by Redmile Group with Participation from Founding Investor Versant Ventures

Social media about Lycia Therapeutics

• Lycia Therapeutics on Wikipedia, Google News & Yahoo Finance
• Lycia Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Tim Anderson

Call Lycia Therapeutics at +1 858...

View the org chart

Register to receive your alert

Report an error